Treatment of neuroectodermal brain tumors.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001254:Astrocytoma / Q000628:therapy; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D002330:Carmustine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005910:Glioma / Q000473:pathology; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use; D008875:Middle Aged; D008940:Mitotic Index; D009837:Oligodendroglioma / Q000628:therapy; D011446:Prospective Studies; D011897:Random Allocation; D012673:Semustine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D012673:Semustine; D008130:Lomustine; D002330:Carmustine